Bellus: 2Q Earnings Snapshot
LAVAL, Quebec (AP) _ Bellus Health Inc. (BLUSF) on Thursday reported a loss of $5.9 million in its second quarter.
On a per-share basis, the Laval, Quebec-based company said it had a loss of 4 cents.
The drug developer posted revenue of $6,000 in the period.
The company’s shares closed at $2.24. A year ago, they were trading at 46 cents.